Drug intelligence / Profile preview

MBS-MA01

Development stage: Preclinical
Lead developer: Microbio
Modality: Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration: Subcutaneous

Overview

MBS-MA01 (also known as SNS851) is a preclinical-stage nucleic acid therapeutic being developed by Shanghai Microbio Technology for the treatment of metabolic diseases and weight loss. As a nucleic acid-based drug, likely utilizing small interfering RNA (siRNA) technology, MBS-MA01 is designed to regulate energy balance and increase the body's metabolic rate. The program leverages the developer's expertise in RNA-based medicine to address obesity and related metabolic disorders by modulating specific pathways involved in energy homeostasis. It is currently in the preclinical phase of development.

Targets

AGO2 (Protein Argonaute-2)

Beyond the preview

Go deeper on MBS-MA01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MBS-MA01.

Explore the full profile